Trusteer, an IBM-owned company that makes malware detection technology mostly for banks, is already using some of the technology in the patent, IBM engineers said Friday.

Scientists used IBM's R2 Heron quantum processor to predict the secondary protein structure of a 60-nucleotide-long mRNA sequence.

The PoC added patterns likely to cause errors in incident response to generative AI and linked an application supporting a series of operations in event detection with IBM supercomputer watsonx ...